Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-166822

Director sold 337,248 shares at an average $20.21 ($6,815,190)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kersten Dirk · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-17 Sale : show line 1 in the form 10b5-1 −211,974 $20.29 $4,301,292 4,332,799 I
2026-04-20 Sale : show line 2 in the form 10b5-1 −125,274 $20.07 $2,513,898 4,207,525 I
Open-market sales · 337,248 sh · avg $20.21 · $6,815,190
Loading xslF345X06/ownership.xml…